LifeVantage Co. (NASDAQ:LFVN) Short Interest Update

LifeVantage Co. (NASDAQ:LFVN - Get Free Report) was the target of a large drop in short interest during the month of May. As of May 15th, there was short interest totalling 1,780,000 shares, a drop of 12.7% from the April 30th total of 2,040,000 shares. Based on an average trading volume of 188,500 shares, the days-to-cover ratio is currently 9.4 days. Approximately 17.6% of the company's shares are short sold.

LifeVantage Stock Up 1.1%

Shares of LFVN traded up $0.14 during midday trading on Friday, reaching $12.52. The company had a trading volume of 100,400 shares, compared to its average volume of 145,202. The stock has a market cap of $157.60 million, a PE ratio of 22.36 and a beta of 0.43. LifeVantage has a 1-year low of $5.22 and a 1-year high of $27.38. The firm has a 50 day simple moving average of $13.04 and a 200-day simple moving average of $16.22.

LifeVantage (NASDAQ:LFVN - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, topping analysts' consensus estimates of $0.16 by $0.10. The business had revenue of $58.44 million during the quarter, compared to analysts' expectations of $60.99 million. LifeVantage had a return on equity of 34.29% and a net margin of 3.46%.

LifeVantage Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 30th will be issued a dividend of $0.045 per share. The ex-dividend date of this dividend is Friday, May 30th. This is a boost from LifeVantage's previous quarterly dividend of $0.04. This represents a $0.18 dividend on an annualized basis and a dividend yield of 1.44%. LifeVantage's dividend payout ratio is currently 26.09%.

Hedge Funds Weigh In On LifeVantage

A number of hedge funds have recently modified their holdings of LFVN. Cubist Systematic Strategies LLC purchased a new position in LifeVantage during the 1st quarter valued at about $97,000. Brown Advisory Inc. purchased a new position in LifeVantage during the 1st quarter valued at about $150,000. Cannon Global Investment Management LLC acquired a new stake in LifeVantage in the 1st quarter valued at about $156,000. State of Wyoming acquired a new stake in LifeVantage in the 1st quarter valued at about $173,000. Finally, XTX Topco Ltd acquired a new stake in LifeVantage in the 1st quarter valued at about $186,000. 35.32% of the stock is currently owned by hedge funds and other institutional investors.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.